{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:48:27Z","timestamp":1780544907321,"version":"3.54.1"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000930","name":"National Stroke Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000930","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neurotrauma Research Program of Western Australia"},{"name":"University of Western Australia Pathfinder Grant"},{"DOI":"10.13039\/501100001800","name":"University of Notre Dame Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001800","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sir Charles Gairdner Hospital"},{"name":"Perron Institute for Neurological and Translational Science"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193884","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T18:45:52Z","timestamp":1520448352000},"page":"e0193884","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies"],"prefix":"10.1371","volume":"13","author":[{"given":"Diego","family":"Milani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Bakeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane L.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince W.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Anderton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Blacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville W.","family":"Knuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0964-0648","authenticated-orcid":true,"given":"Bruno P.","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10571-013-9999-3","article-title":"The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures","volume":"34","author":"BP Meloni","year":"2014","journal-title":"Cell Mol Neurobiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/jcbfm.2015.11","article-title":"Poly-arginine and arginine-rich peptides are neuroprotective in stroke models","volume":"35","author":"BP Meloni","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pharmthera.2015.06.002","article-title":"Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties","volume":"153","author":"BP Meloni","year":"2015","journal-title":"Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12017-017-8441-2","article-title":"Assessment of the neuroprotective effects of arginine-rich protamine peptides, poly-arginine peptides (R12-cylic, R22) and arginine-tryptophan containing peptides following in vitro excitotoxicity and\/or permanent middle cerebral artery occlusion in rats","volume":"19","author":"BP Meloni","year":"2017","journal-title":"Neuromol Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-016-0253-z","article-title":"Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model","volume":"17","author":"D Milani","year":"2016","journal-title":"BMC Neurosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2372710","article-title":"The R18 poly-arginine peptide is more effective than the TAT\u2013NR2B9c (NA-1) peptide when administered 60 minutes after permanent middle cerebral artery occlusion in the rat","volume":"2016","author":"D Milani","year":"2016","journal-title":"Stroke Res Treat"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neures.2016.09.002","article-title":"Neuroprotective efficacy of R18 poly-arginine and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat","volume":"114","author":"D Milani","year":"2017","journal-title":"Neurosci Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12031-016-0861-1","article-title":"The neuroprotective peptide poly-arginine-12 (R12) reduces cell surface levels of NMDA NR2B receptor subunit in cortical neurons; investigation into the involvement of endocytic mechanisms","volume":"61","author":"G MacDougall","year":"2017","journal-title":"J Mol Neurosci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-016-2882-z","article-title":"Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides in neuronal glutamic acid excitotoxicity model","volume":"426","author":"AB Edwards","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"ref10","article-title":"Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improve behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat","author":"AB Edwards","journal-title":"Molecular Brain"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"22030","DOI":"10.1074\/jbc.M115.662791","article-title":"Inhibition of N-methyl-D-aspartate-induced retinal neuronal death by polyarginine peptides is linked to the attenuation of stress-induced hyperpolarization of the inner mitochondrial membrane potential","volume":"290","author":"J Marshall","year":"2015","journal-title":"J Biol Chem"},{"key":"ref12","first-page":"e17161","article-title":"independently of Dapk1","volume":"6","author":"J McQueen","year":"2017","journal-title":"Elife"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"SR Schwarze","year":"1999","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10611860290031886","article-title":"Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy","volume":"10","author":"C Rousselle","year":"2002","journal-title":"J Drug Target"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/hmg\/ddr217","article-title":"Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum","volume":"20","author":"L Du","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.027","article-title":"Efficient transduction of 11 poly-arginine peptide in an ischemic lesion of mouse brain","volume":"23","author":"Y Gotanda","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e0139652","DOI":"10.1371\/journal.pone.0139652","article-title":"Cell-penetrating peptides selectively cross the blood-brain barrier in vivo","volume":"10","author":"S Stalmans","year":"2015","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature10841","article-title":"Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain","volume":"483","author":"DJ Cook","year":"2012","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2012.175","article-title":"Restoring neuroprotection through a new preclinical paradigm: translational success for NA-1 in stroke therapy","volume":"34","author":"R Instrum","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"ref20","unstructured":"Field randomization of NA-1 therapy in early responders (FRONTIER). The Internet Stroke Centre. 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.strokecenter.org\/trials\/clinicalstudies\/field-randomization-of-na-1-therapy-in-early-responders\/description\" xlink:type=\"simple\">http:\/\/www.strokecenter.org\/trials\/clinicalstudies\/field-randomization-of-na-1-therapy-in-early-responders\/description<\/ext-link>."},{"key":"ref21","unstructured":"Safety and efficacy of NA-1 in subjects undergoing endovascular thrombectomy for stroke (ESCAPE-NA1). The Internet Stroke Centre. 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.strokecenter.org\/trials\/clinicalstudies\/safety-and-efficacy-of-na-1-in-subjects-undergoing-endovascular-thrombectomy-for-stroke-escape-na1\" xlink:type=\"simple\">http:\/\/www.strokecenter.org\/trials\/clinicalstudies\/safety-and-efficacy-of-na-1-in-subjects-undergoing-endovascular-thrombectomy-for-stroke-escape-na1<\/ext-link>."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1515\/BC.2003.044","article-title":"In vitro uptake and stability study of pVEC and its all-D analog","volume":"384","author":"A Elmquist","year":"2003","journal-title":"Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1073\/pnas.0407677102","article-title":"Partial D-amino acid substitution: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide","volume":"102","author":"R Tugyi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3858\/emm.2010.42.7.052","article-title":"A serum-stable branched dimeric anti-VEGF peptide blocks tumor growth via anti-angiogenic activity","volume":"42","author":"JW Kim","year":"2010","journal-title":"Exp Mol Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1523\/JNEUROSCI.2491-09.2009","article-title":"Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington&apos;s disease","volume":"29","author":"J Fan","year":"2009","journal-title":"J Neurosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1101\/lm.1765710","article-title":"Src inhibition reduces NR2B surface expression and synaptic plasticity in the amygdala","volume":"17","author":"L Sinai","year":"2010","journal-title":"Learn Mem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"37778","DOI":"10.1074\/jbc.M111.255455","article-title":"Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2)","volume":"286","author":"JM Brittain","year":"2011","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1074\/jbc.M113.518472","article-title":"Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na<sup>+<\/sup>\/Ca<sup>2+<\/sup> exchanger and regulates their functional activity","volume":"289","author":"T Brustovetsky","year":"2014","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","article-title":"The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity","volume":"83","author":"A Garc\u00eda-Caballero","year":"2014","journal-title":"Neuron"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1523\/JNEUROSCI.2212-09.2009","article-title":"Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP","volume":"29","author":"J Xu","year":"2009","journal-title":"J Neurosci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/j.pain.0000000000000147","article-title":"A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors","volume":"156","author":"L Fran\u00e7ois-Moutal","year":"2015","journal-title":"Pain"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.expneurol.2015.09.005","article-title":"Phosphorylation of TRPV1 by cyclin-dependent kinase 5 promotes TRPV1 surface localization, leading to inflammatory thermal hyperalgesia","volume":"273","author":"J Liu","year":"2015","journal-title":"Exp Neurol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/j.pain.0000000000000628","article-title":"Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential","volume":"157","author":"JY Xie","year":"2016","journal-title":"Pain"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1471-4159.2011.07383.x","article-title":"NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury","volume":"118","author":"DR Cook","year":"2011","journal-title":"J Neurochem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1471-4159.2007.04645.x","article-title":"Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury","volume":"102","author":"LA O'Donnel","year":"2007","journal-title":"J Neurochem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2014.03.037","article-title":"Apelin-13 protects the brain against ischemia\/reperfusion injury through activating PI3K\/Akt and ERK1\/2 signaling pathways","volume":"568","author":"Y Yang","year":"2014","journal-title":"Neurosci Lett"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1096\/fj.15-279620","article-title":"Manipulation of the N-terminal sequence of the Borna disease virus X protein improves its mitochondrial targeting and neuroprotective potential","volume":"30","author":"CA Ferr\u00e9","year":"2016","journal-title":"FASEB J"},{"issue":"Pt A","key":"ref38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.expneurol.2017.10.014","article-title":"Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury","volume":"299","author":"X Cheng","year":"2018","journal-title":"Exp Neurol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.24087","article-title":"Innate defense regulator peptide 1018 protects against perinatal brain injury","volume":"75","author":"H Bolouri","year":"2014","journal-title":"Ann Neurol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2337\/diabetes.47.7.1114","article-title":"Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis","volume":"47","author":"I Giardino","year":"1998","journal-title":"Diabetes"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.bjp.0701924","article-title":"Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence","volume":"124","author":"G Yildiz","year":"1998","journal-title":"Br J Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1472-8206.1999.tb00358.x","article-title":"Antioxidant properties of aminoguanidine","volume":"13","author":"C Courderot-Masuyer","year":"1999","journal-title":"Fundam Clin Pharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1124\/mol.61.5.1081","article-title":"Functional and analytical evidence for scavenging of oxygen radicals by L-arginine","volume":"61","author":"A Lass","year":"2002","journal-title":"Mol Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-3565(25)10545-4","article-title":"Strain-dependent drug effects in rat middle cerebral artery occlusion model of stroke","volume":"274","author":"A Sauter","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1161\/01.STR.0000177486.85508.4d","article-title":"Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging","volume":"36","author":"J Bardutzky","year":"2005","journal-title":"Stroke"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/002367706775404426","article-title":"Experimental stroke: ischaemic lesion volume and oedema formation differ among rat strains (a comparison between Wistar and Sprague-Dawley rats using MRI)","volume":"40","author":"M Walberer","year":"2006","journal-title":"Lab Anim"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.brainres.2008.06.110","article-title":"Combined magnesium and mild hypothermia (35\u00b0C) treatment reduces infarct volumes after permanent middle cerebral artery occlusion in the rat at 2 and 4, but not 6 hours","volume":"1230","author":"K Campbell","year":"2008","journal-title":"Brain Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1242\/jcs.02460","article-title":"Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization","volume":"118","author":"M Fotin-Mleczek","year":"2005","journal-title":"J Cell Sci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1995.2756","article-title":"Effect of polycation peptides on mitochondrial permeability transition","volume":"217","author":"MP Rigobello","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"K Zhao","year":"2004","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2010080808","article-title":"Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury","volume":"22","author":"HH Szeto","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bbabio.2015.06.006","article-title":"Disruption of cytochrome c heme coordination is responsible for mitochondrial injury during ischemia","volume":"1847","author":"AV Birk","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.1021\/bi034784f","article-title":"Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity","volume":"42","author":"M Gaczynska","year":"2003","journal-title":"Biochemistry"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jmb.2008.09.021","article-title":"Molecular basis for proline- and arginine-rich peptide inhibition of proteasome","volume":"384","author":"A Anbanandam","year":"2000","journal-title":"J Mol Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejpb.2008.10.016","article-title":"The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities","volume":"72","author":"A Kloss","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.atherosclerosis.2014.06.020","article-title":"Cationic peptides neutralize Ox-LDL, prevent its uptake by macrophages, and attenuate inflammatory response","volume":"236","author":"AN Chandrakala","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.peptides.2014.03.017","article-title":"Identification of multifunctional peptides from human milk","volume":"56","author":"SM Mandal","year":"2014","journal-title":"Peptides"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1476-5381.1965.tb01626.x","article-title":"On the anti-inflammatory activity of protamine sulphate and of hexadimethrine bromide, inhibitors of plasma kinin formation","volume":"24","author":"DN Kellett","year":"1965","journal-title":"Br J Pharmacol Chemother"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nchembio.1393","article-title":"Immune modulation by multifaceted cationic host defense (antimicrobial) peptides","volume":"9","author":"AL Hilchie","year":"2013","journal-title":"Nat Chem Biol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"e0182057","DOI":"10.1371\/journal.pone.0182057","article-title":"A synthetic cationic antimicrobial peptide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP","volume":"12","author":"LH Li","year":"2017","journal-title":"PLoS One"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s10753-014-9864-7","article-title":"L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils","volume":"37","author":"OF Sharifov","year":"2014","journal-title":"Inflammation"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.atherosclerosis.2009.07.019","article-title":"Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2)","volume":"208","author":"G Datta","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"36741","DOI":"10.1074\/jbc.M003848200","article-title":"Polyarginines are potent furin inhibitors","volume":"275","author":"A Cameron","year":"2000","journal-title":"J Biol Chem"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"36788","DOI":"10.1074\/jbc.M400484200","article-title":"Inhibition of furin by polyarginine-containing peptides: nanomolar inhibition by nona-D-arginine","volume":"279","author":"MM Kacprzak","year":"2004","journal-title":"J Biol Chem"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/mol.106.027946","article-title":"Short polybasic peptide sequences are potent inhibitors of PC5\/6 and PC7: use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences","volume":"71","author":"M Fugere","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/08892220151126508","article-title":"Safe use of the CXCR4 inhibitor ALX40-4C in humans","volume":"17","author":"BJ Doranz","year":"2001","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:04:38Z","timestamp":1751465078000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193884"}},"subtitle":[],"editor":[{"given":"Alexander A.","family":"Mongin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193884","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]}}}